A retrospective review of institutional protocol using fondaparinux for anticoagulation therapy in adults with renal failure and suspected heparin‑induced thrombocytopenia.
This study reviews a protocol to safely administer fondaparinux in scenarios where it is the only alternative.
Educational Objectives
Educational Aim:
The aim of this article was to provide a retrospective review of a new Fondaparinux Protocol used to reduce the risk of blood thickening and clot formation in adults with kidney disease and heparin-induced thrombocytopenia where no other treatment was available.
Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:
Why the literature recommends against the use of fondaparinux in patients with kidney failure and dialysis.
When and why pharmacokinetic parameters were altered, and levels changed in this protocol.
What peak anti-factor Xa activity level was targeted and how it affected dosing in this protocol.
Instructions for this Module
- Read the supplied reading material and complete the quiz that follows;
- You have three attempts to pass the quiz;
- The pass grade is 70%;
- You need to pass the quiz to claim your CPD certificate;
- Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.
If you need any assistance to complete this module, please Contact us